Results 161 to 170 of about 1,019 (188)

Spesolimab-sbzo

American Journal of Health-System Pharmacy, 2022
openaire   +2 more sources

Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome

JAMA Dermatology
This case report describes a patient with Sweet syndrome whose condition improved with spesolimab after failure of high-dose corticosteroids.
Zhiyu, Pang, Chao, Wu, Jie, Liu, Yuehua, Liu, Hongzhong, Jin   +4 more
openaire   +2 more sources

Treatment Outcomes and Management of Generalized Pustular Psoriasis with Spesolimab

SKIN The Journal of Cutaneous Medicine
Introduction: Generalized pustular psoriasis (GPP) is a rare, chronic, inflammatory skin disease characterized by sudden, widespread eruption (flare) of sterile pustules often with systemic symptoms.
Joe Tung, Thomas Selby, Maria Aleshin, Angad Chadha, Jacquelyn R Dosal, Laura Rezac, Brooke Walterscheid, Ella Solomon, Lauren Stephens, Benjamin Workman   +9 more
semanticscholar   +1 more source

Rapid improvement in refractory acrodermatitis continua of Hallopeau with spesolimab injection

Clinical and Experimental Dermatology
We present the case of a patient with acrodermatitis continua of Hallopeau (ACH) who was resistant to traditional therapies such as acitretin, ciclosporin and methotrexate, as well as secukinumab and ustekinumab, who was successfully treated with subcutaneous spesolimab, resulting in rapid resolution of skin lesions.
Yong He, Jingshu Xiong, Mengli Zhang, Haoxiang Xu, Hao Chen   +4 more
openaire   +2 more sources

Rapid Resolution of Pediatric Acrodermatitis Continua of Hallopeau With Spesolimab

Pediatrics
Acrodermatitis continua of Hallopeau (ACH) is a sterile pustular psoriasis variant that is refractory to conventional therapies. The eruption typically develops following local trauma or infection, with other potential etiological factors including neural, inflammatory, and genetic origins.
Haiyang He, Yi Liu, Xinlin Zhu, Weihua Pan, Chao Zhang   +4 more
openaire   +1 more source

Subcutaneous spesolimab for GPP flare prevention

Medicom Conference Report WCD 2023, 2023
openaire   +1 more source

Spesolimab appears successful in hidradenitis suppurativa

Medicom Conference Report WCD 2023, 2023
openaire   +1 more source

Spesolimab use in generalised pustular psoriasis flares

The Lancet
Sara, Osborne, Shivani, Thacker, Olivia, Kam, Raquel, Wescott, Jashin J, Wu   +4 more
openaire   +2 more sources

11 Spesolimab use in treatment of severe pyoderma Gangrenosum

Journal of Investigative Dermatology, 2023
S. Guenin, S. Khattri, M. Lebwohl
openaire   +1 more source

Treatment of Netherton syndrome with spesolimab

Journal of the European Academy of Dermatology and Venereology
Juan Bai, Xinyi Chen, Jianjun Qiao, Hong Fang   +3 more
openaire   +2 more sources